Predictive biomarkers in radioresistant rectal cancer: A systematic review

Anna Slipsager(Aalborg University Hospital), Laurids Østergaard Poulsen(Aalborg University Hospital), Mattias Belting(Uppsala University), Karen Dybkær(Aalborg University Hospital), Sture Falkmer(Aalborg University Hospital), Sofie N. Henrichsen(Aalborg University Hospital)
Critical Reviews in Oncology/Hematology
April 13, 2023
10.1016/j.critrevonc.2023.103991
Cited by 9

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
|Blood|2009|390
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362
Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells
|Nature Communications|2016|301